ES2039291T3 - Procedimiento para la obtencion de 3-aminosidnoniminas substituidas y su empleo. - Google Patents

Procedimiento para la obtencion de 3-aminosidnoniminas substituidas y su empleo.

Info

Publication number
ES2039291T3
ES2039291T3 ES198989100274T ES89100274T ES2039291T3 ES 2039291 T3 ES2039291 T3 ES 2039291T3 ES 198989100274 T ES198989100274 T ES 198989100274T ES 89100274 T ES89100274 T ES 89100274T ES 2039291 T3 ES2039291 T3 ES 2039291T3
Authority
ES
Spain
Prior art keywords
substituted
aminosidnoniminas
procedure
obtaining
denotes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198989100274T
Other languages
English (en)
Inventor
Karl Dr. Schonafinger
Rudi Dr. Beyerle
Helmut Dr. Bohn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Cassella AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassella AG filed Critical Cassella AG
Application granted granted Critical
Publication of ES2039291T3 publication Critical patent/ES2039291T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/98—Nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/04—1,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/12—1,4-Thiazines; Hydrogenated 1,4-thiazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

LAS 3 - AMINOSIDNONIMINAS SUSTITUIDAS DE LA FORMULA I Y SUS SALES DE ADICION DE ACIDOS FARMACOLOGICAMENTE ACEPTABLES, DONDE A ES, POR EJEMPLO, - CH2 -, R1 ES HIDROGENO, -NO O EL RESTO -COR4, R (AL CUADRADO) ES, POR EJEMPLO, ALQUILO CON 1-4 ATOMOS DE CARBONO, R4 ES, POR EJEMPLO, UN RESTO ALIFATICO CON 1 - 4 ATOMOS DE CARBONO, SE OBTIENEN POR CICLIZACION DE UN COMPUESTO DE LA FORMULA II SEGUIDA EN SU CASO POR ACILACION O NITRACION, Y POSEEN VALIOSAS CUALIDADES FARMACOLOGICAS.
ES198989100274T 1988-01-14 1989-01-09 Procedimiento para la obtencion de 3-aminosidnoniminas substituidas y su empleo. Expired - Lifetime ES2039291T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3800830A DE3800830A1 (de) 1988-01-14 1988-01-14 Substituierte 3-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung

Publications (1)

Publication Number Publication Date
ES2039291T3 true ES2039291T3 (es) 1993-09-16

Family

ID=6345233

Family Applications (2)

Application Number Title Priority Date Filing Date
ES89100275T Expired - Lifetime ES2045197T3 (es) 1988-01-14 1989-01-09 N-substituidos-n-nitroso-aminoacetonitrilos, procedimiento para su fabricacion y utilizacion.
ES198989100274T Expired - Lifetime ES2039291T3 (es) 1988-01-14 1989-01-09 Procedimiento para la obtencion de 3-aminosidnoniminas substituidas y su empleo.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES89100275T Expired - Lifetime ES2045197T3 (es) 1988-01-14 1989-01-09 N-substituidos-n-nitroso-aminoacetonitrilos, procedimiento para su fabricacion y utilizacion.

Country Status (15)

Country Link
US (1) US4937241A (es)
EP (2) EP0324408B1 (es)
JP (2) JPH0276852A (es)
KR (1) KR890011878A (es)
AT (2) ATE63117T1 (es)
CA (2) CA1329200C (es)
DE (3) DE3800830A1 (es)
DK (2) DK14389A (es)
ES (2) ES2045197T3 (es)
GR (2) GR3002567T3 (es)
HU (2) HU207730B (es)
IE (1) IE61284B1 (es)
MX (1) MX9203756A (es)
PT (1) PT89457B (es)
ZA (1) ZA89253B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4015236A1 (de) * 1990-05-13 1991-11-14 Cassella Ag Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung
DE3921460A1 (de) * 1989-06-30 1991-01-03 Cassella Ag Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung
DE3921796A1 (de) * 1989-07-03 1991-01-17 Cassella Ag Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung
DE59001784D1 (de) * 1989-11-30 1993-07-22 Cassella Ag Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung.
DE4216310A1 (de) * 1992-05-16 1993-11-18 Cassella Ag Salze von 3-(cis-2,6-Dimethylpiperidino)-sydnonimin
FR2703047B1 (fr) * 1993-03-25 1995-06-09 Hoechst Lab Derives nitres de la sydnonimine, leur procede de preparation et leur application comme medicament.
DE4321109C2 (de) * 1993-06-25 1998-01-29 Sanol Arznei Schwarz Gmbh Pharmakologisch aktive Verbindungen mit Nitrosohydrazinpartialstruktur
DE4337335A1 (de) * 1993-11-02 1995-05-04 Cassella Ag Verfahren zur Herstellung von Sydnoniminium-hydrogensulfaten
US20040002615A1 (en) * 2002-06-28 2004-01-01 Allen David Robert Preparation of chiral amino-nitriles

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1496056A (fr) * 1964-06-08 1967-09-29 Takeda Chemical Industries Ltd Nouveaux composés chimiques du type sydnonimine
US4002652A (en) * 1974-05-23 1977-01-11 Morton-Norwich Products, Inc. 2-Substituted-5,6-dimethoxyindazoles
US4009177A (en) * 1974-05-23 1977-02-22 Morton-Norwich Products, Inc. Compound 2-(2-thiazolyl)-5,6-dimethoxyindazoles
US4014886A (en) * 1974-05-23 1977-03-29 Morton-Norwich Products, Inc. 2-Substituted-5,6-dimethoxyindazoles
US4014878A (en) * 1974-05-23 1977-03-29 Morton-Norwich Products, Inc. 2-(3-Morpholinopropyl)-5,6-dimethoxy indazole
US3966760A (en) * 1974-05-23 1976-06-29 Morton-Norwich Products, Inc. 2-Substituted-5,6-dimethoxyindazoles
DE3702083A1 (de) * 1987-01-24 1988-08-04 Cassella Ag Allylmercaptoacetyl-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
CA1329200C (en) 1994-05-03
KR890011878A (ko) 1989-08-23
EP0324408A1 (de) 1989-07-19
DK14389A (da) 1989-07-15
IE890089L (en) 1989-07-14
ES2045197T3 (es) 1994-01-16
DK14389D0 (da) 1989-01-13
HU9203400D0 (en) 1993-01-28
EP0327808A1 (de) 1989-08-16
GR3002567T3 (en) 1993-01-25
PT89457A (pt) 1990-02-08
DK85593A (da) 1993-07-19
DE3800830A1 (de) 1989-07-27
ZA89253B (en) 1989-09-27
HUT54147A (en) 1991-01-28
CA1327362C (en) 1994-03-01
PT89457B (pt) 1993-12-31
EP0327808B1 (de) 1991-05-02
MX9203756A (es) 1992-09-01
DK85593D0 (da) 1993-07-19
HU207730B (en) 1993-05-28
DE58900439D1 (de) 1991-12-19
GR3003575T3 (es) 1993-03-16
JPH0276852A (ja) 1990-03-16
IE61284B1 (en) 1994-10-19
ATE63117T1 (de) 1991-05-15
JPH01216990A (ja) 1989-08-30
EP0324408B1 (de) 1991-11-13
US4937241A (en) 1990-06-26
DE58900098D1 (de) 1991-06-06
ATE69444T1 (de) 1991-11-15

Similar Documents

Publication Publication Date Title
ES2063097T3 (es) Inhibidor de la glicosidasa salbostatina, procedimiento para su preparacion y su empleo.
ES493376A0 (es) Procedimiento para la preparacion de mezclas de aclaradores opticos
ES2062443T3 (es) Nuevos derivados peptidicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2039291T3 (es) Procedimiento para la obtencion de 3-aminosidnoniminas substituidas y su empleo.
NO841870L (no) Peresterforbindelser
ES493375A0 (es) Procedimiento para la preparacion de mezclas de aclaradores opticos
MX9203577A (es) Nuevos derivados de sinergistinas y composiciones farmaceuticas que los contienen.
ES2038794T3 (es) Procedimiento para la obtencion de derivados del azolil-propenil- y azolilmetiloxirano y fungicidas que les contienen.
ES2066756T3 (es) Nuevos derivados de tironina.
ES2046496T3 (es) Procedimiento para la preparacion de agentes de hidroxialquilacion, los nuevos agentes asi obtenidos y su empleo.
ATE92070T1 (de) Azachromanderivate.
ES2032838T3 (es) Un procedimiento para preparar derivados tetrahidropirido (1,2-a)indol.
ES2062313T3 (es) 13-bromo- y 13,14-dibromo-ergolinas, a su preparacion y a su utilizacion en medicamentos.
ES2032573T3 (es) Procedimiento de preparacion de derivados de 4,4-dimetil-tetrahidropir-2-ona.
ES2023760A6 (es) Procedimiento para la preparacion de derivados benzotiazinicos.
ES2038389T3 (es) Procedimiento para la obtencion de 3-aminosidnoniminas substituidas farmacologicamente activas.
ES2057282T3 (es) 3-aminosidnoniminas substituidas, procedimiento para su obtencion y su empleo.
ES518417A0 (es) Un procedimiento para la preparacion de esteres fluorofenoxibencilicos.
ES544709A0 (es) Procedimiento para la obtencion de iminosulfonamidas
DK358383A (da) Fremgangsmaade til fremstilling af alfa-substituerede alkylarylketaler
AR248017A1 (es) Procedimiento para preparar 1 1 1 1 1
MX9204659A (es) Nuevas 3-(tetrazolil substituido)-oxo-4h-pirido-(1,2-a)-pirimidinas, sales de los mismos, las composiciones farmaceuticas que contienen a los mismos y procedimientos para prepararlas

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 327808

Country of ref document: ES